Table I.

Distribution of USP9X status in prostate cancer according to the clinicopathological characteristics of the patients.

		USP9X expression, n
Characteristics	Patients, n	Negative/low	High	P-value
Age, years				0.7074
<65	33	19	14
≥65	69	37	32
Tumor-node-metastasis stage				0.3103
I–II	52	26	26
III–IV	50	30	20
Gleason score				0.0046a
≤7	40	15	25
>7	62	41	21
T stage				0.0138a
T1-T2	62	28	34
T3-T4	40	28	12
Lymph node metastasis				0.7045
Absent	76	41	35
Present	26	15	11
Metastasis				0.6715
Absent	71	38	33
Present	31	18	13

^aP<0.05. USP9X, ubiquitin-specific protease 9X.